Attorneys general from several states, including New York and California, announced Wednesday a $26 billion proposed global settlement to resolve opioid lawsuits against four companies, including Johnson & Johnson.

The announcement comes two years after many of the same states first negotiated the proposed deal, which resolves the vast majority of more than 4,000 lawsuits against the three largest distributors of opiate pharmaceuticals: AmerisourceBergen Drug Corp., McKesson Corp. and Cardinal Health Inc. It also resolves claims against Johnson & Johnson’s Janssen Pharmaceuticals Inc.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]